BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 29934701)

  • 1. Flavonoid mixture (diosmin, troxerutin, rutin, hesperidin, quercetin) in the treatment of I-III degree hemorroidal disease: a double-blind multicenter prospective comparative study.
    Corsale I; Carrieri P; Martellucci J; Piccolomini A; Verre L; Rigutini M; Panicucci S
    Int J Colorectal Dis; 2018 Nov; 33(11):1595-1600. PubMed ID: 29934701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flavonoids mixture (diosmin, troxerutin, hesperidin) in the treatment of acute hemorrhoidal disease: a prospective, randomized, triple-blind, controlled trial.
    Giannini I; Amato A; Basso L; Tricomi N; Marranci M; Pecorella G; Tafuri S; Pennisi D; Altomare DF
    Tech Coloproctol; 2015 Jun; 19(6):339-45. PubMed ID: 25893991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conservative Treatment of Hemorrhoids: Results of an Observational Multicenter Study.
    Zagriadskiĭ EA; Bogomazov AM; Golovko EB
    Adv Ther; 2018 Nov; 35(11):1979-1992. PubMed ID: 30276625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Micronized purified flavonidic fraction compared favorably with rubber band ligation and fiber alone in the management of bleeding hemorrhoids: randomized controlled trial.
    Ho YH; Tan M; Seow-Choen F
    Dis Colon Rectum; 2000 Jan; 43(1):66-9. PubMed ID: 10813126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Micronized flavonoid therapy in internal hemorrhoids of pregnancy.
    Buckshee K; Takkar D; Aggarwal N
    Int J Gynaecol Obstet; 1997 May; 57(2):145-51. PubMed ID: 9184951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hemorrhoids and conservative treatment. Review of the literature on the use of diosmin and micronized hesperidin].
    La Torre F; Nicolai AP; Otti M
    Minerva Chir; 1999 Dec; 54(12):909-16. PubMed ID: 10736998
    [No Abstract]   [Full Text] [Related]  

  • 7. Parenteral troxerutin and carbazochrome combination in the treatment of post-hemorrhoidectomy status: a randomized, double-blind, placebo-controlled, phase IV study.
    Basile M; Gidaro S; Pacella M; Biffignandi PM; Gidaro GS
    Curr Med Res Opin; 2001; 17(4):256-61. PubMed ID: 11922398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective, randomized, controlled, observer-blinded trial of combined infrared photocoagulation and micronized purified flavonoid fraction versus each alone for the treatment of hemorrhoidal disease.
    Dimitroulopoulos D; Tsamakidis K; Xinopoulos D; Karaitianos I; Fotopoulou A; Paraskevas E
    Clin Ther; 2005 Jun; 27(6):746-54. PubMed ID: 16117981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Pycnogenol on the Healing of Venous Ulcers.
    Toledo RR; Santos MERC; Schnaider TB
    Ann Vasc Surg; 2017 Jan; 38():212-219. PubMed ID: 27521821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Conservative treatment of patients with varicose esophagus veins cirrhosis].
    Patrushev NB; Koviazina IO; Lazebnik LB
    Eksp Klin Gastroenterol; 2010; (11):40-5. PubMed ID: 21485513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advantage of a micronized flavonoidic fraction (Daflon 500 mg) in comparison with a nonmicronized diosmin.
    Amato C
    Angiology; 1994 Jun; 45(6 Pt 2):531-6. PubMed ID: 8203783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-blind, placebo-controlled evaluation of clinical activity and safety of Daflon 500 mg in the treatment of acute hemorrhoids.
    Cospite M
    Angiology; 1994 Jun; 45(6 Pt 2):566-73. PubMed ID: 8203789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-Term Effects of Supplemental L-Arginine, Diosmin, Troxerutin, and Hesperidin in Diabetic Patients: A Pilot Study.
    Bagnati M; Puricelli C; Bauce G; Basile M; Grigollo B; Prodam F; Dianzani U; Bellomo G; Rolla R
    Biomed Res Int; 2021; 2021():3508281. PubMed ID: 34901269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the Efficacy and Safety of a Compound of Micronized Flavonoids in Combination With Vitamin C and Extracts of
    Gravina AG; Pellegrino R; Facchiano A; Palladino G; Loguercio C; Federico A
    Front Pharmacol; 2021; 12():773320. PubMed ID: 34970145
    [No Abstract]   [Full Text] [Related]  

  • 15. Prospective randomized controlled trial of a micronized flavonidic fraction to reduce bleeding after haemorrhoidectomy.
    Ho YH; Foo CL; Seow-Choen F; Goh HS
    Br J Surg; 1995 Aug; 82(8):1034-5. PubMed ID: 7648143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic potential of micronized purified flavonoid fraction (MPFF) of diosmin and hesperidin in treatment chronic venous disorder].
    Hnátek L
    Vnitr Lek; 2015 Sep; 61(9):807-14. PubMed ID: 26465280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is There a Difference in the Clinical Efficacy of Diosmin and Micronized Purified Flavonoid Fraction for the Treatment of Chronic Venous Disorders? Review of Available Evidence.
    Cazaubon M; Benigni JP; Steinbruch M; Jabbour V; Gouhier-Kodas C
    Vasc Health Risk Manag; 2021; 17():591-600. PubMed ID: 34556990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flavonoids to reduce bleeding and pain after stapled hemorrhoidopexy: a randomized controlled trial.
    Mlakar B; Kosorok P
    Wien Klin Wochenschr; 2005 Aug; 117(15-16):558-60. PubMed ID: 16158207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical effectiveness of a highly standardized and bioavailable mixture of flavonoids and triterpenes in the management of acute hemorroidal crisis.
    Di Pierro F; Spinelli G; Monsù G; Alvisi G; Bacci G; Baiocchi C; Buratta M; Martinoli A; Vitali F; Agrifoglio C; Gennaioli F; Lucarelli M
    Acta Biomed; 2011 Apr; 82(1):35-40. PubMed ID: 22069954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Administration of Micronized Purified Flavonoid Fraction During Sclerotherapy of Reticular Veins and Telangiectasias: Results of the National, Multicenter, Observational Program VEIN ACT PROLONGED-C1.
    Bogachev VY; Boldin BV; Turkin PY
    Adv Ther; 2018 Jul; 35(7):1001-1008. PubMed ID: 29949043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.